熱門資訊> 正文
第11章的Clearside Biomedical文件
2025-11-24 20:28
- Clearside Biomedical (CLSD) filed for voluntary Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court for the District of Delaware as of November 24, 2025.
- The company is pursuing a strategic sale of its business through a structured Chapter 11 process aimed at maximizing stakeholder value.
- As part of the bankruptcy case, Clearside (CLSD) intends to conduct an auction and sale process allowing interested parties to submit binding offers to acquire Clearside's assets, free and clear of liens and interests.
- The stock price tumbled ~70% to $0.82 on Monday during pre-market hours of trading.
More on Clearside Biomedical
- Seeking Alpha’s Quant Rating on Clearside Biomedical
- Historical earnings data for Clearside Biomedical
- Financial information for Clearside Biomedical
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
